Why the study?
Does minoxidil increase aldosterone metabolic clearance in hypertensive patients?
Does minoxidil increase aldosterone metabolic clearance in hypertensive patients?
Minoxidil increases aldosterone metabolic clearance, likely due to increased hepatic perfusion, which explains why plasma aldosterone levels do not rise despite minoxidil-induced increases in plasma renin activity.
Answers are grounded in this paper and cite their sources.
Minoxidil may enhance aldosterone clearance via hepatic flow in hypertension; leaves open effects on renin-aldosterone dynamics or outcomes.
It has been shown that despite an effect of minoxidil to increase PRA, plasma levels of aldosterone do not change. We observed similar findings in seven hypertensive patients undergoing treatment with minoxidil; PRA activity increased markedly, whereas the plasma aldosterone concentration showed no consistent change. The aldosterone MCRs in these patients increased by 41% in response to minoxidil, from 1110 +/- 91 to 1570 +/- 180 (SEM) liters/day; this appeared to explain why plasma aldosterone levels did not increase in parallel with renin activity. Hepatic blood flow (estimated from the clearance of indocyanine green) in a group of patients receiving minoxidil was greater than that in an otherwise comparable group (P less than 0.02). This increase in hepatic perfusion may, at least in part, have accounted for the increase in aldosterone MCR.
No takes yet. Share an insight, caveat, or question.
Pratt et al. (1979) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: